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Abstract 
Background: Bilateral adrenalectomy has been shown to damage the hippocampal neurons. Although the effects 
of long‑term adrenalectomy have been studied extensively there are few publications on the effects of short‑term 
adrenalectomy. In the present study we aimed to investigate the effects of short‑term bilateral adrenalectomy on the 
levels of pro‑inflammatory cytokines IL‑1β, IL‑6 and TNF‑α; the response of microglia and astrocytes to neuronal cell 
death as well as oxidative stress markers GSH, SOD and MDA over the course of time (4 h, 24 h, 3 days, 1 week and 
2 weeks) in the hippocampus of Wistar rats.
Results: Our results showed a transient significant elevation of pro‑inflammatory cytokines IL‑1β and IL‑6 from 4 h 
to 3 days in the adrenalectomized compared to sham operated rats. After 1 week, the elevation of both cytokines 
returns to the sham levels. Surprisingly, TNF‑α levels were significantly elevated at 4 h only in adrenalectomized com‑
pared to sham operated rats. The occurrence of neuronal cell death in the hippocampus following adrenalectomy 
was confirmed by Fluoro‑Jade B staining. Our results showed a time dependent increase in degenerated neurons in 
the dorsal blade of the dentate gyrus from 3 days to 2 weeks after adrenalectomy. Our results revealed an early activa‑
tion of microglia on day three whereas activation of astroglia in the hippocampus was observed at 1 week postop‑
eratively. A progression of microglia and astroglia activation all over the dentate gyrus and their appearance for the 
first time in CA3 of adrenalectomized rats hippocampi compared to sham operated was seen after 2 weeks of surgery. 
Quantitative analysis revealed a significant increase in the number of microglia (3, 7 and 14 days) and astrocytes (7 
and 14 days) of ADX compared to sham operated rats. Our study revealed no major signs of oxidative stress until 
2 weeks after adrenalectomy when a significant decrease of GSH levels and SOD activity as well as an increase in MDA 
levels were found in adrenalectomized compared to sham rats.
Conclusion: Our study showed an early increase in the pro‑inflammatory cytokines followed by neurodegeneration 
and activation of glial cells as well as oxidative stress. Taking these findings together it could be speculated that the 
early inflammatory components might contribute to the initiation of the biological cascade responsible for subse‑
quent neuronal death in the current neurodegenerative animal model. These findings suggest that inflammatory 
mechanisms precede neurodegeneration and glial activation.
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Background
Glucocorticoids are steroid hormones produced in 
the adrenal gland and secreted in the blood stream in 
response to the circadian rhythm as well as stress situa-
tions [1]. The human and rodent versions of these hor-
mones are cortisol and corticosterone respectively. It is 
well known since the second half of last century that the 
hippocampus is the main target of these hormones due 
to the high level of their receptors [2]. In addition, several 
other brain areas such as the amygdala, neocortex, hypo-
thalamus are targets of the adrenal hormones because 
they contain mineralo and or glucocorticoid receptors 
[3].
Immunohistochemical studies showed glucocorticoid 
receptors in the brain are of two types, mineralocorticoid 
or type 1 and glucocorticoid or type 2 receptors [4]. The 
abundance of these receptors in the hippocampus dif-
fers from one neuronal population to another where the 
granule cells are rich in type 1 and pyramidal neurons in 
type 2 receptors. In the brain such hormones, in addition 
to their suppressive effect of inflammatory mediators 
[5], they play a major role in the production of neuro-
trophin-3 (NT-3), Brain Derived Growth factor (BDNF), 
Nerve Growth Factor (NGF) [6–9].
Several studies showed dual effect of these hormones 
on the hippocampus. It has been reported chronic 
administration of high dose of glucocorticoids results 
in degeneration of pyramidal neurons [10]. However, 
multiple studies have demonstrated that adrenalectomy 
(ADX) induced massive and selective degeneration of the 
granule cells of the dentate gyrus [11–13]. Moreover, in 
addition to granule cells degeneration, pyramidal cells 
degeneration were observed in the hippocampus after 
long-term adrenalectomy.
The discovery by Sloviter et al. [11] that adrenalectomy 
induces hippocampal granule cell loss and the duplication 
of this finding by several groups [7, 14–16] as well as the 
findings by Sapolsky et al. [17] and Adem et al. [18] that 
showed hippocampal pyramidal cell loss after long-term 
adrenalectomy have established this model as a neuro-
degenerative model of hippocampal cells. Moreover, the 
neurodegeneration and glial response to the cell death 
that takes place in the this model is comparable to what 
is seen in other established neurodegenerative models 
such ischemia [19, 20], surgical injury [21], Trimethyltin 
(TMT) [22] KA (kainic acid) [23] and cis-2,4-methano-
glutamate (MGlu) [24]. Hence the ADX model can be 
used as an experimentally controlled neuronal cell death 
in the hippocampus which might be a relevant model to 
what is happening in neurodegenerative disorders.
Pro-inflammatory cytokines interleukin-1β (IL-1β) 
[25–27], Interleukin-6 (IL-6) [28, 29] and tumor necrosis 
factor alpha (TNF-α) [27, 30, 31] have been shown to be 
produced by different cells in the brain [19]. Elevated 
levels of such cytokines have been found in numer-
ous degenerative diseases such as Alzheimer’s disease 
(AD) [32, 33], Amyotrophic lateral sclerosis (ALS) [25] 
and Parkinson’s disease (PD) [34, 35]. Different stud-
ies showed the early expression of cytokines in various 
neurodegenerative animal models in which kainic acid 
[36], TMT [37], ischemia–reperfusion [38, 39], 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [40, 41] 
treatments were used. It has been reported that these 
inflammatory mediators are involved in initiation of the 
morphological changes which occur during neuronal 
death and exacerbation of the damage induced by differ-
ent insults [42–47].
Oxidative stress is well-known as a cytotoxic phe-
nomenon when imbalance between the antioxidants 
and oxidants occurs leading to different aspects of tis-
sue endangerment and subsequently contribution to the 
neurodegenerative process [48–51]. Reactive oxygen spe-
cies (ROS) have important physiological functions [52, 
53]. Production of high levels of ROS can cause oxidative 
stress. Since oxidative stress can induce cell damage and 
promote inflammation [54], cells have a battery of anti-
oxidizing molecules and enzymes to prevent the accumu-
lation of ROS [55].
The aim of this study was to examine the impact of 
short-term bilateral adrenalectomy on production of pro-
inflammatory cytokines, the activation of different glial 




Eight-week old male Wistar rats 170–220 g were obtained 
from College of Medicine and Health Sciences animal 
facility (Al Ain, UAE) and used in the current study. 
Under Pentobarbital (35 mg/kg body weight) anesthesia, 
rats were subjected either to adrenalectomy or to sham 
operation (laparotomy) as described by Sloviter et  al. 
[11], the naive animals were left untouched. Age matched 
naïve control groups were also used. All animals were 
placed in Plexiglas cages; four rats per group, maintained 
in a temperature (22 °C) and 12:12 light–dark cycle con-
ditions, animals received ad  libitum access to food and 
water throughout the experiment. Adrenalectomized rats 
were provided with 0.9 % saline in place of drinking water 
in order to maintain electrolyte balance and prevent the 
deleterious effects of sodium chloride insufficiency. The 
regional ethical committee of the College of Medicine 
and Health Sciences (UAE University) approved this 
study (RECA/01/05).
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Determination of plasma corticosterone levels
The levels of corticosterone in the serum were used to 
assess the efficacy of adrenalectomy, approximately 1 ml 
blood samples were taken directly from the heart at the 
time of sacrifice. For both biochemical and histological 
assessments (n = 120) rats were sacrificed by decapitation 
after surgery at different time points: 4 h (n = 24), 24 h 
(n = 24), 3 days (n = 24), 1 week (n = 24) and 2 weeks 
(n =  24). The sera samples were stored at −80  °C until 
corticosterone levels were measured by Enzyme Immu-
noassay (EIA) Kit (Life sciences, Lausen, Switzerland). 
The assay is based on the competitive binding technique 
as described by the manufacturer. Briefly, a polyclonal 
antibody specific for corticosterone becomes bound to 
the donkey anti-sheep antibody coated onto the micro-
plate. Following a wash to remove excess polyclonal anti-
body, corticosterone present in the serum competes with 
a fixed amount of horseradish peroxidase (HRP)-labeled 
corticosterone for sites on the polyclonal antibody. This is 
followed by another wash to remove excess of the conju-
gate and unbound sample. A substrate solution is added 
to the wells to determine the bound enzyme activity. The 
color development is stopped and the absorbance is read 
at 450 nm. The intensity of the color is inversely propor-
tional to the concentration of corticosterone in the sam-
ple. A standard curve in the range 32–20,000 pg/ml was 
constructed to calculate corticosterone concentrations in 
the samples.
Enzyme‑linked immunosorbent assay (ELISA)
Animals (n  =  80) were sacrificed by decapitation after 
surgery at different times: 4  h (Sham  =  8, ADX  =  8), 
24 h (Sham = 8, ADX = 8), 3 days (Sham = 8, ADX = 8), 
1 week (Sham =  8, ADX =  8) and 2 weeks (Sham =  8, 
ADX =  8). Similarly naïve controls (n =  8) were sacri-
ficed by decapitation. The brain was removed, the hip-
pocampus was immediately dissected out on ice, frozen 
in liquid nitrogen and stored at −80  °C until assayed. 
Thawed hippocampal tissues were homogenized in ice-
cold T-PER tissue extraction buffer (Pierce Biotech-
nology, Rockford, IL,USA), supplemented with 1:100 
protease inhibitor cocktail (Sigma, Saint Louis, MO, 
USA). After sonication, samples were centrifuged at 
16,000 rpm for 30 min at 4  °C and the supernatant was 
collected and stored at −80 °C until use. Protein concen-
trations were determined using Bradford’s protein assay 
kit (Bio-Rad, Stockholm, Sweden) and levels of cytokines 
(IL-1β, IL-6, TNF-α) were assessed by ELISA using the 
commercially provided antibodies and standard proteins 
(R&D Systems; Minneapolis, USA).
Briefly, standard 96-well flat-bottom NUNC-Immu-
nomaxisorp ELISA plates (NUNC, Roskilde, Denmark) 
were incubated at room temperature (RT) overnight with 
the captured antibody, which binds the cytokine of inter-
est. The next day the plates were blocked by incubation 
for 2  h at RT with 1  % bovine serum albumin (Sigma, 
Saint Louis, MO, USA) in PBS. Serial dilutions of known 
amounts of standard protein were applied in duplicate 
for the standard curve. The plates containing the stand-
ard proteins and supernatants of hippocampal tissue 
homogenates were incubated at RT for overnight.
The following day, the plates were incubated with the 
corresponding biotinylated detecting antibody for 1 h at 
RT. An avidinylated antibody conjugated to horseradish 
peroxidase (HRP) as a tertiary reactant was incubated for 
20 min at RT. Tetramethylbenzidine (41.6 mM) at 100 μl 
per well was used to develop color. The reaction was ter-
minated with 2 M sulfuric acid and the absorbance was 
recorded at 450 nm in a plate reader within 10 min after 
stopping of the reaction. The levels of IL-1β, IL-6 and 
TNF-α were evaluated by comparison with the regression 
curve for each cytokine standard. Calculated cytokine 
concentrations were normalized to the total protein con-
centrations obtained in the Bradford’s protein assay for 
each sample. Cytokines concentration is reported as pg of 
cytokine/mg of protein.
FJB staining
Fluoro-Jade B staining was performed as described by 
Schmued and Hopkins [56]. 32 animals, 4 h (Sham = 4, 
ADX = 4), 24 h (Sham = 4, ADX = 4), 3 days (Sham = 4, 
ADX =  4), 1  week (Sham =  4, ADX =  4) and 2  weeks 
(Sham =  4, ADX =  4) were used for this staining. The 
coronal sections of the brain were first deparaffinized 
through two changes of xylene each 10  min and then 
rehydrated through a graduated alcohol series. The slides 
were immersed in 1 % sodium hydroxide in 80 % alcohol 
(20 ml of 5 % NaOH added to 80 ml absolute alcohol) for 
5 min. The slides are then kept in 70 % alcohol and in dis-
tilled water for 2  min respectively. The slides were then 
transferred to a solution of 0.06 % potassium permanga-
nate for 10 min. The slides were then rinsed in distilled 
water for two min and immersed in 0.0004 % Fluoro-Jade 
B (Darmstadt, Germany) for 20 min. The slides were then 
rinsed for one min in each of three distilled water washes 
and placed on a slide warmer for 10 min. The dry slides 
were cleared by immersion in xylene for at least 1  min 
and were then cover slipped with DPX.
Immunoflurescent labeling
Animals (n = 32) were sacrificed after surgery at differ-
ent times: 4  h (Sham =  4, ADX =  4), 24  h (Sham =  4, 
ADX  =  4), 3  days (Sham  =  4, ADX  =  4), 1  week 
(Sham = 4, ADX = 4) and 2 weeks (Sham = 4, ADX = 4). 
Animals were deeply anesthetized with intra-peritoneal 
administration of sodium pentobarbital (35 mg/kg body 
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weight) and perfused transcardially through the ascend-
ing aorta, with 50 ml of 0.1 M phosphate-buffered saline 
followed by 300  ml of freshly prepared solution of 4  % 
formaldehyde in 0.1  M phosphate buffer. Brains were 
removed and post fixed for 1 week in the same fixative at 
4 °C. All tissues were then dehydrated through an ethanol 
series, cleared in 100 % xylene and embedded in paraffin. 
A 1 μm coronal sections (n = 10 per animal) of the brain 
were selected approximately −3.7 mm relative to bregma 
according to Paxinos and Watson [57] and mounted on 
gelatin subbed slides.
For all fluorescence labeling, the paraffin-embedded 
tissue sections were deparaffinized with xylene, rehy-
drated with ethanol (100, 90, 80, and 70  %) and finally 
washed in distilled water. To unmask the epitopes and 
obtain efficient immunostaining, the brain sections were 
subjected to an antigen retrieval procedure with 10 mM 
Sodium Citrate (pH 6) followed by microwave heating for 
1 min at high power and 10 min at low power. After this 
procedure the samples were washed with 0.1  M phos-
phate buffered saline (PBS, pH 7.4) and cooled down at 
room temperature.
For double-immunofluorescence labeling, the sections 
were blocked by 1 % BSA at room temperature for 30 min 
and then were incubated with each primary antibody at 
4  °C overnight. The primary antibodies used were rab-
bit polyclonal anti-ionized calcium-binding adaptor 
molecule 1 (Iba1, Wako, MA, USA 1:2000) mixed with 
mouse monoclonal anti-neuronal nuclear antigen anti-
body (Neun, Millipore, MA, USA, 1:1000) and rabbit 
polyclonal anti-glial fibrillary acidic protein (GFAP, Dako, 
Copenhagen, Denmark, 1:1000) mixed with mouse mon-
oclonal anti-neuronal nuclear antigen (Neun, Millipore, 
MA, USA, 1:1000). After washing three times in PBS, 
tissue sections were incubated with donkey anti-rabbit 
conjugated to Alexa 488 (Invitrogen, Paisley, UK, 1:200) 
mixed with donkey anti-mouse conjugated to Rhodamine 
(Jakson, Pennsylvania, USA, 1:100) all diluted in PBS-Tri-
ton X-100 0.3 % for 1 h at room temperature. Afterwards, 
the sections were washed several times in PBS; slides 
were cover slipped with fluoromount medium.
Similar procedure was used for triple-immunofluo-
rescence labeling in order to define the localization of 
microglia, astroglia and neurons in the same brain sec-
tion, the mixture of the following primary antibodies 
was used, rabbit GFAP (Dako, Copenhagen, Denmark, 
1:1000) mixed with mouse Neun (Millipore, MA, USA, 
1:1000) and goat Iba1 (Abcam, MA, USA 1:1000) at 4 °C 
overnight. Regarding the secondary antibody, tissue sec-
tions were incubated with donkey anti-rabbit conjugated 
to Alexa 488 (Invitrogen, Paisley, UK, 1:200) mixed with 
donkey anti-mouse conjugated to Rhodamine (Jakson, 
Pennsylvania, USA, 1:100) and donkey anti-goat conju-
gated to cy5 (Jakson, Pennsylvania, USA, 1:100).
Representative digital images were captured using a 
Zeiss AxioCamHRc Digital camera with AxioVision 3.0 
software (Carl Zeiss, Germany). Some sections were also 
examined with a C1 laser scanning confocal microscope 
(Nikon, Tokyo, Japan). 4× and 20× objectives were used 
to capture confocal images for the preparation of Figs. 3, 
5 and 7 respectively where only one optical section was 
utilized. The resulting files were used to generate the 
figures in Adobe PhotoShopCS6 where the photomicro-
graphs were adjusted for contrast and brightness in order 
to determine the relationship between labeled neurons, 
astrocytes and microglia.
Quantitative analysis of the Iba‑l and GFAP positive cells
Both microglia and astrocytes undergo morphological 
changes and became reactive cells in response to CNS 
injury. In this study we investigated the response of both 
these glial cells in the hippocampus after ADX. Typi-
cally, reactive microglia show shortening and widening 
of their processes and some of them they show amoe-
boid shape by losing their processes. Reactive astrocytes 
show increased size of their processes. These features 
can be easily visualized in sections stained with Iba1 and 
GFAP antibodies as markers for microglia and astro-
cytes respectively (Figs.  3, 5). In this study, only posi-
tively stained Iba1-positive microglia and GFAP-positive 
astrocytes with visible cell body at the focal plane were 
counted. Three ADX and three sham rats were used for 
each time point. Three sections of the hippocampus sep-
arated by 30 µm were used from each rat. From each sec-
tion three optical fields were selected for cell counting. 
Images of stained sections were taken at 20× magnifica-
tion using an AxioCam HRc Digital camera with AxioVi-
sion 3.0 software (Carl Zeiss, Germany). In order to avoid 
being biased, the parameters of acquiring images like the 
time of exposure and the gain were first fixed for labeled 
microglia and astroglia and kept constant for all the 
examined time points. Cells matching the above men-
tioned criteria were counted manually using cell counter 
software (Heracle BioSoft SRL, Romania). A comparison 
was then carried out between the number of microglia 
and astrocytes in ADX and sham operated rats.
Colorimetric assay
Animals (n  =  80) were sacrificed by decapitation after 
surgery at different times: 4  h (Sham  =  8, ADX  =  8), 
24 h (Sham = 8, ADX = 8), 3 days (Sham = 8, ADX = 8), 
1 week (Sham =  8, ADX =  8) and 2 weeks (Sham =  8, 
ADX  =  8). The brain was removed, the hippocampus 
was immediately dissected out on ice, frozen in liquid 
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nitrogen and stored at −80  °C until use for the colori-
metric assays to determine the levels of oxidative stress 
markers GSH, SOD and MDA.
The concentration of reduced glutathione (GSH) was 
determined in whole tissue supernatant. The hippocam-
pal sample was first deproteinized with the 5 % of 5-sul-
fosalicylic acid solution followed by centrifugation to 
remove the precipitated protein and then assayed for 
glutathione using the commercial kit (Sigma, Saint Louis, 
MO, USA). The measurement of GSH uses a kinetic 
assay in which catalytic amounts (nmoles) of GSH cause 
a continuous reduction of 5, 5′-dithiobis (2-nitrobenzoic 
acid) (DTNB) to TNB and the GSSG formed is recycled 
by glutathione reductase and NADPH. The yellow prod-
uct, 5-thio-2-nitrobenzoic acid (TNB) is measured spec-
trophotometrically at 412 nm. The assay uses a standard 
curve of reduced glutathione to determine the amount of 
glutathione in the sample [58].
SODs are metalloenzymes that catalyze the dismuta-
tion of the superoxide radical (O2·−) into hydrogen per-
oxide (H2O2) and molecular oxygen (O2). The assay kit 
utilizes a tetrazolium salt for detection of superoxide 
radicals generated by xanthine oxidase and hypoxanthine 
by using the commercial kit (Cayman Chemical, MI, 
and USA). One unit of SOD is defined as the amount of 
enzyme needed to exhibit 50 % dismutation of the super-
oxide radical. The plate was read at 440  nm using plate 
reader.
The measurement of the TBARS amount in the hip-
pocampal homogenate is based on the interaction of 
thiobarbituric acid (TBA) with malondialdehyde (MDA) 
under acid conditions (acetic acid) and higher tempera-
ture (95  °C) (Cayman Chemical, MI, USA), the formed 
TBA-MDA adduct measured colorimetrically at 530–
540  nm. The MDA level was evaluated by comparison 
with the regression curve for standard.
Statistical analysis
All data are reported as the mean  ±  standard error of 
the mean and the analysis was considered significantly 
different if P ≤  0.05. Results were analyzed by one way 
ANOVA for (IL-1β, IL-6 and TNF-α) and two-tail Stu-
dent t test for (GSH, SOD and MDA) and microglia and 
astrocytes counting using SPSS version 20 (IBM, USA).
Results
Efficacy of adrenalectomy was confirmed post-mortem 
by analysis of plasma corticosterone levels. The levels of 
corticosterone were significantly decreased in the sera 
of adrenalectomized compared to bilateral sham oper-
ated rats after 4  h (P  =  0.001), 24  h (P  <  0.001), 72  h 
(P < 0.001), 1 week (P < 0.001), 2 weeks (P < 0.001) of sur-
gery (Fig. 1).
Increase in pro‑inflammatory cytokines at early stages 
of adrenalectomy
The levels of pro-inflammatory cytokines IL-1β, IL-6 and 
TNF-α in the hippocampal homogenates of adrenalecto-
mized, sham operated and naive rats were examined by 
ELISA over the course of time (4 h, 24 h, 3 days, 1 week 
and 2 weeks).
The levels of IL-1β were significantly increased in the 
hippocampus of adrenalectomized rats compared to 
bilateral sham operated rats after 4  h (P  <  0.05), 24  h 
(P < 0.05) and 3 days (P < 0.01) of surgery. However, one 
and 2 weeks after adrenalectomy no statistical difference 
in the hippocampal levels of IL-1β were found between 
the two groups. The comparison of both groups to the 
naive revealed that the levels of IL-1β were significantly 
increased in sham (P < 0.05) and ADX (P < 0.001) after 
4  h, and 24  h, 3  days. After 1 week the statistical sig-
nificance persisted only between the naïve and sham 
(P < 0.01). After 2 weeks the levels of IL-1β decreased sig-
nificantly in both sham (P < 0.001) and ADX (P < 0.001) 
compared to the naïve rats group (Fig. 2a).
Regarding the pro-inflammatory cytokine IL-6, a sig-
nificant increase in its levels was observed in the hip-
pocampus 4  h (P  <  0.01), 24  h (P  <  0.01) and 3  days 
(P  <  0.05) after adrenalectomy. However, no change 
was seen in IL-6 levels after 1 and 2 weeks post-
operatively. The comparison of both groups to the 
naive showed that the levels of IL-6 was significantly 
increased in sham (P < 0.01) and ADX (P < 0.001) after 
4 h, 24 h, and 3 days. After 1 week the statistical sig-
nificance continued between sham (P  <  0.01), ADX 
(P  <  0.05) and the naïve. 2 weeks later there is still a 
Fig. 1 Bar graphs showing levels of plasma corticosterone. Levels of 
corticosterone were measured by EIA in the serum of adrenalecto‑
mized rats compared to the sham operated rats over the course of 
time (4 h, 24 h, 3 days, 1 week and 2 weeks). ***P < 0.001. Data are 
expressed as mean (±SEM)
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significant high level of IL-6 in the sham (P < 0.01) and 
ADX (P  <  0.01) groups compared to the naïve group 
(Fig. 2b).
The levels of TNF-α were significantly increased 
in the hippocampus of adrenalectomized rats com-
pared to bilateral sham operated rats after 4  h only 
(P < 0.01). No statistical differences between the sham 
operated and naïve groups was seen over the course of 
time. However, a significant elevation of hippocampal 
TNF-α levels was only observed in the ADX (P < 0.001) 
compared to naïve rats after 4 h following the surgery 
(Fig. 2c).
Neuronal cell death after adrenalectomy
In order to examine the occurrence of neuronal cell death 
in the hippocampus following adrenalectomy over a course 
of time (4 h, 24 h, 3 days, 1 week and 2 weeks), a Fluoro-
Jade B staining was performed. FJB staining is a specific 
staining for neurons undergoing degeneration, regardless 
of the specific insult or mechanism of cell death.
After 4 h (results not shown) and 24 h following adre-
nalectomy our results showed no positive staining for 
degenerated neurons in both groups ADX and sham rats 
(Fig. 3A, A’, E, E’). 3 days after adrenalectomy we observed 
a few degenerated neurons in the dorsal blade of the den-
tate gyrus in the hippocampii of adrenalectomized rats 
only (Fig. 3B, B’, F, F’). Moreover, 1 week after adrenalec-
tomy, more degenerated neurons were seen on the dorsal 
blade of the dentate gyrus (Fig. 3C’, G’) whilst no positive 
FJB staining was observed in sham operated rats (Fig. 3C, 
G). After 2 weeks of adrenalectomy, we observed a pro-
gression of cell death throughout the dorsal blade of the 
dentate gyrus (Fig. 3D’, H’) where an intense FJB staining 
was seen. In addition, less intense staining was observed 
in the ventral blade indicating that differential effect of 
the adrenal gland removal on both blades of the dentate 
gyrus. No positive FJB staining was observed in sham 
operated rats (Figs. 3D, H, 4).
Adrenalectomy promotes activation of microglia 
and astroglia
The activation of microglia is one of the major signs of 
neurodegeneration. In order to investigate the activation 
of these cells in response to neurodegeneration occurring 
after short-term adrenalectomy, a double immunofluo-
rescent labeling of neurons (Neun) and microglia (Iba-
1) over the course of time (4 h, 24 h, 3 days, 1 week and 
2 weeks) was performed.
Our immunoflurescent results were seen in different 
animals, in a consistent way and in the same pattern. 
Regarding microgliosis in the hippocampus, the fluores-
cent double immunostaining of neurons and microglia 
of brain sections after 4 h (results not shown) and 1 day 
of adrenalectomy did not show activated microglia in 
adrenalectomized and sham operated groups (Fig.  5A, 
A’). However, after 3 days we observed activated micro-
glia in the dorsal blade of the dentate gyrus of adrenal-
ectomized rats while no sign of activation was seen in 
the sham operated rats (Fig. 5B, B’). 1 week following the 
adrenal gland removal, activated microglia were seen in 
the whole dorsal blade of the dentate gyrus indicating a 
progression of microgliosis (Fig. 5C’). In contrast, no sign 
of activated microglia were observed in the hippocam-
pus of sham operated rats (Fig.  5C). Fluorescent dou-
ble immunostaining of neurons and microglia of brain 
Fig. 2 Bar graphs showing IL‑1, IL‑6 and TNF‑α level in the hip‑
pocampus of adrenalectomized, sham operated and naive rats. Levels 
of IL‑1 (a) IL‑6 (b) and TNF‑α (c) were measured by ELISA over the 
course of time (4 h, 24 h, 3 days, 1 week and 2 weeks). Sham versus 
ADX (*P < 0.05; **P < 0.01). Naive versus sham and ADX (#P < 0.05; 
##P < 0.01; ###P < 001). Data are expressed as mean (±SEM)
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Fig. 3 Images of coronal sections of the hippocampus stained with Fluoro‑Jade B showing the progression of neuronal cell death over the course 
of time (1 day, 3 days, 1 week and 2 weeks) in the dentate gyrus of the hippocampus of adrenalectomized rats compared to sham operated rats. 
Absence of cell death was noticed in the dentate gyrus (A, B, C, D) and (E, F, G, H) of sham operated rats during the different time points (1 day, 
3 days, 1 week and 2 weeks). 1 day after adrenalectomy the rats showed no signs of neuronal cell death in the dentate gyrus (A’) and (E’). A progres‑
sion of neuronal cell death was seen in the dentate gyrus 3 days (B’), 1 week (C’), and 2 weeks (D’) after adrenalectomy. Molecular layer (ML), granule 
cell layer (GCL), polymorphous layers (PL). Scale bar 50 µm
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sections after 2 weeks postoperatively revealed a strong 
Iba-1 immunoreactivity in the hippocampus of adrenal-
ectomized rats most particularly in the dentate gyrus 
(Fig.  5D’) and stratum lucidum (SL) of CA3 (Fig.  5H’) 
areas compared to the corresponding regions in the sham 
operated rats (Fig. 5D, H). Iba-1 labeling exhibited a dif-
ferential distribution throughout the dentate gyrus where 
it shows an intensive microgliosis in the molecular (ML) 
and granule cell layer (GCL) of the dorsal blade and pre-
dominately at the tip where the Neun staining shows 
apparent absence of neurons compared to the ventral 
blade 2 weeks post operatively (Fig.  6). Interestingly, at 
the same time point, we observed for the first time a strip 
of Iba-1 positive cells in the stratum lucidum layer of the 
CA3 area (Fig.  6) and (Fig.  5D’). No sign of microglio-
sis was seen in CA3 area of sham operated rats over the 
course of time (Fig. 5E, F, G, H). 
In order to examine the effect of adrenal gland removal 
on astrocyte immunoreactivity in the hippocampus 
over a course of time (4  h, 24  h, 3  days, 1  week and 
2  weeks), a double immunofluorescent labeling of neu-
rons (Neun) and astrocytes (GFAP) was performed. After 
4 h (results not shown), 1 and 3 days of adrenalectomy, 
we did not observe an apparent difference in the GFAP 
immunoreactivity in the hippocampii of adrenalecto-
mized and sham groups (Fig.  7A, A’, B, B’). However, 1 
week after adrenalectomy, activated astrocytes were seen 
in the dentate gyrus (Fig. 7C’) whilst no difference in the 
GFAP immunoreactivity was observed in sham operated 
rats (Fig. 7C).
An intense GFAP immunoreactivity was observed 2 
weeks after adrenalectomy, throughout the hippocam-
pus most particularly in the dentate gyrus (Fig.  8) 
where the astrocytes undergo morphological changes 
and appeared hypertrophic and showed intense GFAP 
immunoreactivity (Fig.  7D’). The GFAP immuno-labe-
ling exhibited extensive astrogliosis in the molecular 
and polymorphous layers (PL) of the dentate gyrus; 
however less intense astrogliosis was seen in the granu-
lar layer (Fig.  8). The stratum lucidum of CA3 area of 
adrenalectomized rats showed an increase in GFAP 
immunoreactivity (Fig.  7H’). Moreover, GFAP immu-
nostaining also showed extensive astrogliosis in the 
CA4 but not in the CA1 area of the adrenalectomized 
rats (Fig. 8). The dentate gyrus (Fig. 7A, B, C, D), CA3 
(Fig. 7E, F, G, H), CA4, CA2 and CA1 areas in the hip-
pocampi of bilateral sham operated rats did not show 
astrogliosis (Fig. 8).
Fig. 4 Representative confocal images of sections stained with Fluoro‑Jade B (green) showing the occurrence of neurodegeneration after 2 weeks 
in both blades of the dentate gyrus of the hippocampus of adrenalectomized rats compared to sham operated rats. Molecular layer (ML), granule 
cell layer (GCL), polymorphous layers (PL). Scale bar 50 µm
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Fig. 5 Images of coronal sections of the hippocampus stained with NeuN antibody (red) as a neuronal marker and Iba‑1 antibody (green) as a 
microglia marker showing the progression of microgliosis over the course of time (1 day, 3 days, 1 week and 2 weeks) in the dentate gyrus and 
CA3 of the hippocampus of adrenalectomized rats compared to sham operated rats. Absence of microgliosis in the dentate gyrus (A, B, C, D) and 
CA3 (E, F, G, H) of sham operated rats during 1 day, 3 days, 1 week and 2 weeks. The adrenalectomized rats showed no signs of microgliosis in the 
dentate gyrus (A’) and CA3 (E’) after 1 day. However, a progression of microgliosis was seen in the dentate gyrus after 3 days (B’), 1 week (C’) and 
2 weeks (D’). In comparison, the microgliosis in the CA3 of adrenalectomized rats did not appear until after 2 weeks as the Iba1 immunoreactivity 
after 1, 3 days and 1 week was not significantly different from that in sham operated rats. Molecular layer (ML), granule cell layer (GCL), polymor‑
phous layers (PL) and (SL) stratum lucidum. Scale bar 50 µm
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In order to investigate the localization of the activated 
microglia and astrocytes simultaneously after 2  weeks 
of adrenalectomy a triple immunostaining, of neurons 
(Neun), microglia (Iba-1),and astrocytes (GFAP) was per-
formed and the sections were examined with a confocal 
microscope. We observed co-localization of the micro-
glia and astrocytes in different layers of the dentate gyrus 
(Fig. 9).
The quantitative analysis showed that the num-
ber of Iba-1-positive microglia in the hippocampus of 
ADX rats was significantly higher in days 3 (P  <  0.01), 
7 (P < 0.001) and 14 days (P < 0.001) compared to the 
sham operated rats. The results showed progressive 
increase in the number of microglia in the hippocampus 
from day three with a further increase one and 2 weeks 
after adrenalectomy (Fig. 10). On the other hand, there 
was no significant difference between the number of 
GFAP-positive astrocytes in the hippocampus of ADX 
and sham operated rats 3 days following adrenalectomy. 
However, a significant increase (P < 0.001) in the num-
ber of astrocytes was observed one and 2  weeks after 
adrenalectomy in the ADX compared to sham operated 
rats (Fig. 11).
Induction of oxidative stress state in the hippocampus 
after 2 weeks of adrenalectomy
Reduced glutathione (GSH) is the major reducing antioxi-
dant by serving as an electron donor and detoxification of 
free radicals in the cell. As shown in (Fig. 12) the evalua-
tion of the levels of this antioxidant component in the hip-
pocampal homogenates over the course of time (4 h, 24 h, 
3 days, 1 week and 2 weeks) in bilateral adrenalectomized 
rats compared to sham operated indicated no significant 
increase in the first day following surgery, however, at day 
three a significant increase (P < 0.05) in the levels of GSH 
was observed in adrenalectomized rats compared to the 
sham. At 1 week postoperatively, no significant difference 
in the levels of GSH was seen between the two groups, 
however, 2 weeks later we noticed a significant decrease 
(P < 0.05) in GSH levels in adrenalectomized rats.
The measurement of the antioxidant enzyme, super-
oxide dismutase (SOD) activity was performed by a 
Fig. 6 Representative images of coronal sections of the whole hippocampus stained with NeuN (red) and Iba‑1 (green) antibodies showing micro‑
gliosis after 2 weeks of adrenalectomized rats compared to bilateral sham operated rats. Molecular layer (ML), granule cell layer (GCL), polymor‑
phous layers (PL) and (SL) stratum lucidum. Scale bar 100 µm
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Fig. 7 Images of coronal sections of the hippocampus stained with NeuN antibody (red) as a neuronal marker and GFAP antibody (green) as an 
astrocytes marker showing the progression of microgliosis over the course of time (1 day, 3 days, 1 week and 2 weeks) in the dentate gyrus and CA3 
of the hippocampus of adrenalectomized rats compared to sham operated rats. Absence of astrogliosis was noticed in the dentate gyrus  
(A, B, C, D) and CA3 (E, F, G, H) of sham operated rats during the different time points (1 day, 3 days, 1 week and 2 weeks). 1 day and 3 days after adre‑
nalectomy the rats showed no signs of astrogliosis in the dentate gyrus (A’, B’) and CA3 (E’, F’) respectively. A progression of astrogliosis was seen in 
the dentate gyrus after 1 week (C’) and 2 weeks (D’) whilst no immunoreactivity was seen in CA3 after 1 week (G’). However appearance of astrogliosis 
in CA3 was seen after 2 weeks (D’). Molecular layer (ML), granule cell layer (GCL), polymorphous layers (PL) and (SL) stratum lucidum. Scale bar 50 µm
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colorimetric assay in the hippocampal homogenates of 
adrenalectomized compared to sham operated rats. Our 
results indicated no significant changes in SOD activity 
in the hippocampal homogenates of adrenalectomized 
compared to sham operated rats after 4 h, 24 h, 72 h and 
1 week of adrenalectomy. However, 2 weeks after surgery 
a significant decrease in the enzyme activity (P  <  0.01) 
was revealed in the hippocampus of adrenalectomized 
compared to sham operated rats (Fig. 13).
Lipid peroxidation is one of the most important mani-
festations of the imbalance between the antioxidants 
and the oxidants which leads to oxidative stress. We 
examined the occurrence of lipid peroxidation in the 
hippocampus by the measurement of the levels of malon-
dialdehyde (MDA), the lipid peroxidation by-product. No 
statistical differences in the levels of MDA until 2 weeks 
after surgery when a significant increase (P  <  0.05) in 
MDA levels was seen in adrenalectomized rats compared 
to sham operated rats (Fig. 14).
Discussion
The aim of this study was to investigate the effects of 
short-term bilateral adrenalectomy on the levels of pro-
inflammatory cytokines IL-1β, IL-6 and TNF-α, the 
response of microglia and astrocytes to neuronal cell 
death as well as oxidative stress markers GSH, SOD and 
MDA over the course of time (4 h, 24 h, 3 days, 1 week 
and 2 weeks) in the hippocampus.
Our results showed transient elevation of IL-1β and 
IL-6 levels which lasts for 3 days in the hippocam-
pus of adrenalectomized compared to sham operated 
rats. 1  week after adrenalectomy, the elevation of these 
cytokines dropped to sham levels. Both the sham oper-
ated and adrenalectomized rats showed significant ele-
vated IL-1β and IL-6 levels compared to the naïve rats. 
The significant difference between the naïve and sham 
operated animals might be attributed to the surgical 
stress. However, the significant difference between the 
sham and adrenalectomized rats can only be attributed to 
Fig. 8 Representative images of coronal sections of the whole hippocampus stained with NeuN (red) and GFAP (green) antibodies showing astro‑
gliosis after 2 weeks of adrenalectomized rats compared to bilateral sham operated rats. Molecular layer (ML), granule cell layer (GCL), polymor‑
phous layers (PL) and (SL) stratum lucidum. Scale bar 100 µm
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the effect of adrenalectomy. We noted significant differ-
ence in the hippocampal levels of TNF-α between adre-
nalectomized and sham operated rats only at 4  h after 
adrenalectomy.
The occurrence of neuronal cell death in the hip-
pocampus following adrenalectomy was confirmed by 
Fluoro-Jade B stain. Our results showed a time depend-
ent increase in degenerated neurons in the dorsal blade 
of the dentate gyrus from 3 days to 1  week after adre-
nalectomy. 2  weeks after adrenalectomy we observed a 
progression of cell death throughout the dorsal blade of 
the dentate gyrus. These findings are in line with those 
of Spanswick et al. [59] who reported, degenerated neu-
rons throughout the granular layer of the dentate gyrus 
2 weeks after adrenalectomy using Fluoro-Jade B stain-
ing. After 2  weeks we observed little cell death in the 
ventral blade. Our findings indicate that adrenalectomy 
affects differentially the dorsal and ventral blades of the 
dentate gyrus and suggest that the granule cells of the 
dorsal blade of the dentate gyrus are more vulnerable to 
adrenalectomy. In line with our findings, several investi-
gators have observed that the earliest cell death occurs at 
least after 3 days of adrenalectomy [7, 11, 59–61]. How-
ever, few investigators reported cell death on day two 
after adrenalectomy [7, 12, 62].
It is interesting to note that the early elevation of the 
pro-inflammatory cytokines IL-1β, IL-6 and TNF-α was 
seen prior to neuronal death. Taken together our findings 
suggest that cell death was preceded by an increase of 
these pro-inflammatory cytokines. Similar findings have 
been reported in animal models of ischemia [19, 20], sur-
gical injury [21], TMT (Trimethyltin) [22] KA (Kainic 
acid) [23] and cis-2,4-methanoglutamate (MGlu) [24] 
where an early increase of different pro-inflammatory 
cytokines preceded neuronal damage.
Two studies reported the direct involvement of IL-1β 
in neurodegeneration. Rothwell [19] reported the injec-
tion of low doses of IL-1β into the cerebral ventricles or 
Fig. 9 Representative confocal images of sections stained with Neun (red), Iba1 (blue) and GFAP (green) showing the localization of activated 
microglia and astroglia after 2 weeks throughout the dentate gyrus of the hippocampus of adrenalectomized rats compared to sham operated rats. 
Molecular layer (ML), granule cell layer (GCL), polymorphous layers (PL). Scale bar 50 µm
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brain parenchyma of mice or rats exposed to neurotox-
ins markedly exacerbates the damage. The second study 
showed the antagonism of IL-1β by co-infusion of IL-1β 
receptor antagonist with the neurotoxin N-Methyl-D-
aspartate  (NMDA) inhibits brain damage induced by 
such excitotoxin [63, 64]. Moreover, IL-1β plays a cru-
cial role in the exacerbation of acute neurodegeneration 
caused by ischemia, head trauma and stroke. In addition, 
it is implicated in the pathology of multiple sclerosis, 
Alzheimer’s disease and other CNS chronic diseases [24, 
65–67].
IL-6 levels were found to be elevated in the serum and 
CSF of MS patients, locally around MS lesions [68, 69] 
and in experimental auto-immune encephalitis (EAE) 
animal models [70]. IL-6 expression was significantly 
increased in the acute phase of cerebral ischemia [44]. 
In AD patients, IL-6 is further increased locally around 
amyloid plaques and in the CSF [34, 71].Taken together 
our findings suggest that after adrenalectomy IL-1β, IL-6 
and TNF-α might contribute to the initiation of the bio-
logical cascade responsible for subsequent hippocampal 
neuronal cell death.
The activation of microglia is one of the major signs 
of neurodegeneration [71]. Similar to Gould et  al. [60], 
our results showed cell death starts in the dorsal blade of 
the dentate gyrus 3 days after adrenalectomy. Activated 
microglia were observed in the molecular and granu-
lar layers of the dorsal blade of the dentate gyrus 3 days 
after adrenalectomy. 1  week after adrenalectomy as the 
cell death progresses in the dorsal blade the number of 
activated microglia are increased. 2  weeks after adre-
nalectomy we showed that the whole dentate gyrus was 
invaded by activated microglia. In line with these find-
ings, quantitative analysis showed a progressive increase 
in the number of microglia in the hippocampus from day 
three with a further increase 1 and 2  weeks after adre-
nalectomy. Jaarsma et al. [62], using silver impregnation 
staining, observed argyrophilia in the somata and den-
drites of the granular and molecular layers respectively 
and in the mossy fiber terminal zone. Regarding the 
cornu amonis, 2 weeks after adrenalectomy we observed 
invasion of the CA4 by activated microglia. In contrast, 
no sign of microgliosis was seen in the pyramidal cells 
Fig. 10 Bar graphs showing the comparison between the number 
of Iba‑1 positive cells in the hippocampus of adrenalectomized and 
sham operated rats. The number of microglia was significantly and 
progressively increased in adrenalectomized rats 3 days, 1 week and 
2 weeks postoperatively. **P < 0.01; ***P < 0.001. Data are expressed 
as mean (±SEM)
Fig. 11 Bar graphs showing the comparison between the number 
of GFAP positive cells in the hippocampus of adrenalectomized 
and sham operated rats. No difference in the number of astrocytes 
revealed after 3 days but significantly increased 1 and 2 weeks follow‑
ing adrenalectomy. ***P < 0.001. Data are expressed as mean (±SEM)
Fig. 12 Bar graphs showing GSH levels in the hippocampus of adre‑
nalectomized and Sham operated rats. Levels of GSH were measured 
by colorimetric assay over course of time (4 h, 24 h, 3 days, 1 week 
and 2 weeks) in adrenalectomized compared to sham operated 
rats.*P < 0.05. Data are expressed as mean (±SEM)
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of CA3, CA2 and CA1. However, we noticed activated 
microglia along the stratum lucidum of the CA3. Our 
current study showed a strong correlation between cell 
death and microglia activation over the course of time. 
Taken together our observations suggest a correlation 
between microgliosis and cell death.
It is well known that brain injury is associated with 
increased astrocytes reactivity [37]. Astrocytes react pro-
foundly to brain damage or disease by increasing both 
their number and size, a process referred to as reactive 
astrogliosis/astrocytosis which represents a remarkably 
homotypic response to CNS injuries [72]. In this study, 
activation of astrocytes was observed throughout the 
dentate gyrus 1 week after adrenalectomy. However, Kru-
gers et  al. [14] found activation of astrocytes earlier, on 
the third day after adrenalectomy. Although we could not 
see activated astrocytes at day three, it is possible that 
the activation of astrocytes takes place between day 3 
and 7 after adrenalectomy. The observed astrogliosis in 
our study was predominantly in the molecular and poly-
morphous layers of the dentate gyrus whilst no apparent 
astrogliosis was seen in other areas of the hippocampus. 
Our findings are in line with those findings which showed 
astrocytes invasion of the dentate gyrus after TMT injec-
tion. TMT is a selective neurotoxin of granule cells [37]. 
In addition to the activation of astrocytes after 1 week 
in the DG our results showed progressive activation 
of astrocytes in the CA4 and CA3 of the hippocampus 
2 weeks after adrenalectomy. In line with these findings, 
quantitative analysis showed a significant increase in the 
number of astrocytes in the hippocampus from 1  week 
until 2 weeks after adrenalectomy.
Astrocytes are known to communicate with micro-
glia, and such interaction is very important in pathologi-
cal conditions [73, 74]. The progressive degeneration of 
granule cells correlated well with the activation of micro-
glia and astroglia in the dentate gyrus over the course of 
2 weeks.
Our results showed microglia activation on the third 
day followed by astrocytes activation on the seventh 
day after adrenalectomy. These findings are in line with 
what has been found in different neurodegenerative 
models where microglia were found to be the first cells 
to respond to neuronal damage followed by activation of 
astrocytes [75–78]. Taken together these findings suggest 
a cross talk between the two cell populations during neu-
ronal damage and consider microglia as driving force in 
astroglia recruitment.
Oxidative stress occurs when there is an overproduc-
tion, or accumulation of reactive oxygen species (ROS) 
in conjunction with reduced antioxidant capacity within 
the cell [79]. As a response to neuronal death, the quies-
cent microglia became functionally active and upregulate 
enzymes such as inducible nitric oxide synthase (iNOS) 
leading to an imbalance between free radicals production 
and the antioxidant defenses [80].
Our findings showed that a state of oxidative stress 
manifested in the decrease of reduced glutathione 
(GSH) 2  weeks after adrenalectomy. In addition, our 
study showed a significant decrease in the activity of the 
superoxide dismutase. In contrast to the decrease of the 
antioxidant defenses, malondialdehyde (MDA) the indi-
cator of the plasma membrane disruption was signifi-
cantly increased. This imbalance, observed 2 weeks after 
Fig. 13 Bar graphs showing SOD activity in hippocampus of adre‑
nalectomized and sham operated rats. Levels of SOD activity were 
measured by colorimetric assay over the course of time (4 h, 24 h, 
3 days, 1 week and 2 weeks) in adrenalectomized compared to sham 
operated rats.*P < 0.05. Data are expressed as mean (±SEM)
Fig. 14 Bar graphs showing MDA levels in the hippocampus of adre‑
nalectomized and Sham operated rats. Levels of MDA were measured 
by colorimetric assay over course of time (4 h, 24 h, 3 days, 1 week 
and 2 weeks) in adrenalectomized rats compared to sham operated 
rats. *P < 0.05. Data are expressed as mean (±SEM)
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adrenalectomy, reflects a state of oxidative stress which 
possibly resulted from the activated glial cells. It has been 
found after 1 week of adrenalectomy an overexpression of 
iNOS in activated microglia revealing these cells as source 
of the free radical in this model [16]. Taken together our 
findings are consistent with the literature showing that 
several neurodegenerative paradigms revealed the associa-
tion between neuroinflammation accompanied by reactive 
gliosis and a state of oxidative stress [81].
The mechanisms underlying cell degeneration after 
bilateral adrenalectomy are not clear. We have previously 
suggested the possibility that adrenocortical hormones 
might have direct effects on the survival of hippocampal 
neurons. Hippocampal neurons might die when the min-
eralocorticoids (Type I) and/or glucocorticoid (Type II) 
receptors are not occupied by adrenocortical hormones 
[18, 82]. Subsequently, Hu et al. [83] reported that gran-
ule cell death after adrenalectomy was necessarily accom-
panied by the disappearance of glucocorticoid receptor 
immunoreactivity in the granule cell layer. We have 
previously also suggested that the loss of adrenocortical 
hormones after adrenalectomy may cease to stimulate 
a factor(s), in the hippocampus or other tissues, that is 
(are) necessary for the survival of hippocampal neurons 
[18, 82]. It could be speculated that in several neurode-
generative diseases like Alzheimer’s disease, chronic 
adrenal hormones increase and/or their receptors’ 
decrease may result in inflammatory mechanisms which 
lead to hippocampal neurodegeneration [84–88].
Conclusion
Our study showed that short-term bilateral adrenal-
ectomy leads to an early increase in pro-inflammatory 
cytokines followed by neurodegeneration and activation 
of glial cells as well as oxidative stress. Taking these find-
ings together it could be suggested that the early inflam-
matory components might contribute to the initiation 
of the biological cascade responsible for subsequent 
hippocampal neuronal cell death in the current neuro-
degenerative animal model. These findings suggest that 
inflammatory mechanisms precede neurodegeneration 
and glial activation.
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